Caricamento...
Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength
SUMMARY: This study was to determine if antibody against sclerostin (Scl-Ab) could prevent glucocorticoid (GC)-induced osteoporosis in mice. We found that Scl-Ab prevented GC-induced reduction in bone mass and bone strength and that the anabolic effects of Scl-Ab might be partially achieved through...
Salvato in:
| Pubblicato in: | Osteoporos Int |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4958115/ https://ncbi.nlm.nih.gov/pubmed/26384674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-015-3308-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|